Biohaven (BHVN) Total Liabilities (2021 - 2026)

Biohaven has disclosed Total Liabilities across 6 years of filings, most recently posting $336.9 million for Q1 2026.

• Total Liabilities for Q1 2026 came in at $336.9 million, up 68.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $336.9 million (up 68.92% YoY), and the FY2025 annual result was $399.4 million, up 108.36% from the prior year.
• Total Liabilities came in at $336.9 million for Q1 2026 at Biohaven, down from $399.4 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $426.3 million in Q3 2025 to a low of -$46.1 million in Q1 2022.
• The 5-year median for Total Liabilities is $146.3 million (2023), against an average of $177.1 million.
• Peak annual rise in Total Liabilities reached 577.96% in 2023, while the deepest fall reached 30.71% in 2023.
• Biohaven's Total Liabilities stood at $123.0 million in 2022, then sank by 30.71% to $85.2 million in 2023, then jumped by 124.87% to $191.7 million in 2024, then surged by 108.36% to $399.4 million in 2025, then dropped by 15.64% to $336.9 million in 2026.
• The last three Total Liabilities figures came in at $336.9 million (Q1 2026), $399.4 million (Q4 2025), and $426.3 million (Q3 2025), per Business Quant data.